CorMedix (CRMD) Depreciation & Amortization (CF) (2016 - 2025)
CorMedix (CRMD) has disclosed Depreciation & Amortization (CF) for 13 consecutive years, with $294096.0 as the latest value for Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 259.57% to $294096.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $677000.0 through Dec 2025, up 339.61% year-over-year, with the annual reading at $677000.0 for FY2025, 339.61% up from the prior year.
- Depreciation & Amortization (CF) hit $294096.0 in Q4 2025 for CorMedix, up from $161917.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $294096.0 in Q4 2025 to a low of $11994.0 in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $58492.4 across 5 years, with a median of $21826.0 in 2024.
- Biggest five-year swings in Depreciation & Amortization (CF): plummeted 75.15% in 2021 and later soared 535.97% in 2025.
- Year by year, Depreciation & Amortization (CF) stood at $20047.0 in 2021, then rose by 12.32% to $22516.0 in 2022, then decreased by 25.11% to $16863.0 in 2023, then soared by 385.03% to $81790.0 in 2024, then skyrocketed by 259.57% to $294096.0 in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for CRMD at $294096.0 in Q4 2025, $161917.0 in Q3 2025, and $110993.0 in Q2 2025.